DOCSLIB.ORG

Ian Appraisal of Glaxosm,Ithki:Ine Bang,Ladesh Limited' ~ .~~

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Ian Appraisal of Glaxosm,Ithki:Ine Bang,Ladesh Limited' ~ .~~ r e"/- , ,Q ( 0" J IAn Appraisal of GlaxoSm,ithKI:ine Bang,ladesh Limited' ~ .~~ Il Internship Report in Ful:fUlment of Bus-499· Prepared for Dr. Tanbir Ahmed Chowdhury Associate Professor ,.0. • Departm.ent of Business Administration Eas,t West University Prepared by Sifal Pervin to: 1997 ..... 2 -12 - 004 Department of Business Administration East West Uni'Versi,ty EWU Dhaka -1212' December 29" 2001 Letter of Transmittal December 29, 2001 Dr. Tanbir Ahmed Chowdhury Associate Professor Department of Business Administration East West University 45-46 Mohakhali, Dhaka - 1212 Dear sir: It gives me immense pleasure in presenting my internship report on GlaxoSmithKline Bangladesh Limited, which has been assigned as a partial requirement to complete BUS - 499 course. I have the pleasure in forwarding my report in which I have presented an overview of GlaxoSmitKline and revealed about the various areas of functions of the Company. I have also conducted evaluation of financial performance of the Company, identified the prospects and problems of the Company and suggested some remedial methods for the development of GlaxoSmithKline Bangladesh Limited. I have tried to cover all these areas with immense sincerity and best effort. I consider my evaluation, interpretation, opinions and remedial propositions of their problems would lead GSK Bangladesh Ltd. to sustain their growth, be competitive and continue to increase their market share. I would like to take the opportunity to thank you and extend my appreciation towards you for your valuable guidance and constant attention as and when required in accomplishing this report and providing me the opportunity to familiarize the practical aspect of business. I shall be pleased to answer any query you think necessary when needed. Sincerely, Sifo.t .:r~y\y\ Sifat Pervin 10: 1997 -2- 12 - 004 Department of Business Administration East West University Acknowledgement I would like to show my sincerest gratitude and appreciation to my academic advisor Dr. Tanbir Ahmed Chowdhury, Associate professor, Department of Business Administration, East West University. His heartiest guidance and assistance helped me a great deal not only to complete this report but also to gain experience from practical field. I would furthur like to show my gratitude to all the respondents [ corporate officials1 of GlaxoSmithKline Bangladesh Limited for taking their valuable time and providing me with necessary information regarding the report. I express my greatfulness to the foJ/owing officials of GlaxoSmithKline Bangladesh limited: • Md. Moynullslam Group Product Manager • Md. Nizam Uddin Manager - HR Services • Naimul Islam Chowdhury IT System Officer • Md . Masudur Rahman Manager Accounts • Md. Mustafizur Rahman National Distribution Manager • Md. Rokonuzzaman Internal Audit Manager. II Tabl'e of' CQ:ntents Topics Page Number Letter of Transmittal Acknowledgement II Executive Summery III Chapter 1 1. 1 Introduction 1 1.2 Origin of the Report 2 1.3 Objectives of the Study 2 1 .4 Data Collection Method 3 1.5 Scope and Methodology of the Study 3 1.6 Limitations 4 1.7 Background of GlaxoSmithKline 5 (A Global Perspective) 1.7.1. Glaxo Group Limited 5 1.7.2. Burroughs Wellcome 6 1.7.3. Glaxo Wellcome Pic. 7 1.7.4. SmithKline Beecham 7 1.7.5. GlaxoSmithKline 8 1.8 Some Specific Features of GlaxoSmithKline 12 1.8.1. Research and Development 13 1.8.2. Global Manufacturing and Supply 14 1.8.3. GSK in Time 14 Topics Page Number 1 .9 Support and Guidance from the Center 15 1.9.1 . Commercial Development 15 1.9.2. Human Resources 16 1.9.3. Finance 17 1.9.4. Legal Operations 17 1.9.5. Communications 18 1.9.6. Information Technology 19 1.9.7. Procurement 19 1.9.8. International Regulatory Affairs 20 1.9.9. International Government Affairs 21 1.10 GlaxoSmithKline Bangladesh Limited 22 (Company Profile) Chapter 2 2.1 Industry Analysis (Bangladesh Perspective) 25 2.2 Human Resource 27 2.2.1. Average Number of Employees 29 2.2.2. Organogram of GSK Bangladesh Limited 31 2.3 Information Technology 32 2.4 Product 33 a) GlaxoSmithKline Group 33 b) Local Suppliers 33 2.5 Packaging 34 2.6 Labeling 35 2.7 Promotional Strategies 36 2.7.1 . Processes of Promotion 37 a. Marketing Representatives 37 b. Mail 37 Topics Page Number c. Medical Journal 37 d. Promotional Symposiums 37 e. Gifts 38 f. Discounts 38 2.8 Pricing Policies 39 2.9 Terms of Trade 40 i) Cash Basis or Cheque 40 ii) Credit Sales 40 2.10 Distribution 41 (A) Imported 41 (B) Locally Produced 41 2.10.1. Distribution Channel 42 2.11 Environmental Impact 43 2.12 Basis of Accounting 44 Chapter - 3 3.1 Evaluation of Financial Performance 45 3.1.1 . Capacity Utilization 47 3.1 .2. Net Sales 49 3.1.3. Profit After Taxation 53 3.1.4. Earning Per Share 56 3.1 .5. Dividend 57 3.1.6. Dividend Per Share 58 3.1.7. Dividend Payout 59 3.1.8. Net Assets Value Per Share 62 3.1.9. Return on Shareholder's Fund 63 3.1.10. Price/Earning Ratio 64 3.1.11 . Total Funds Employed or Shareholder's Fund 65 3.1.12. Sales Position of the Company 66 Topics Page Number 3.2 Trend Analysis by Following the 68 Ordinary Least Square Method 3.2 .1. Trend Analysis of Net Sales 70 3.2.2. Trend Analysis of Earning Per Share 73 3.2.3. Trend Analysis of Dividend 75 3.2.4. Trend Analysis of Profit After Taxation 78 3.2.5. Trend Analysis of Shareholder's Fund 80 3.2.6. Trend Analysis of Return on Shareholder's Fund 83 3.3 Share Capital Position 87 3.4 Position of Shares Holding 88 Chapter 4 4. 1 Prospects 89 4.2 Problems 95 Chapter 5 5.1 Recommendations 98 5.2 Conclusion 101 Appendix-A Locally Manufactured Products Price List 102 Imported Products Price List 104 Appendix- B Questionnaire 106 Appendix-C Bibliography 110 List o.f Tables. and Grap,hs, Tables and Graphs Page Number Chapter 2 2.2.1. Average Number of Employees Table and Graph 2.2.1. 29 2.2.2. Distribution of Executives Table and Graph 2.2.2. 30 2.10.1 . Distribution Channel of GSK Bangladesh Limited Figure 2.10.1 42 Chapter 3 3.1.1. Capacity Utilization Table 3. 1. 1. 47 3.1.2. Net Sales Table and Graph 3.1.2. 49 3.1.3. Profit After Taxation Table and Graph 3.1.3, 53 3.1.4. Earning Per Share Table and Graph 3.1.4. 56 3.1.5. Dividend Table and Graph 3.1 .5. 57 3.1.6. Dividend Per Share Table and Graph 3.1.6. 58 3.1.7. Dividend Payout Table and Graph 3.1.7. 59 Tables and Graphs Page Number 3.1 .8. Net Assets Value Per Share Table and Graph 3.1 .8. 62 3.1 .9. Return on Shareholder's Fund Table and Graph 3.1.9. 63 3.1.10. Price! Earning Ratio Table and Graph 3.1 .10. 64 3.1.11 . Total Funds Employed or Shareholder's Fund Table and Graph 3.1.11 . 65 3.1.12. Sales Position of the Company Table 3.1.12. 66 3.2.1 . Trend Analysis of Net Sales Table 3.2.1 . 70 3.2.2. Trend Analysis of Earning Per Share Table 3.2.2. 73 3.2.3. Trend Analysis of Dividend Table 3.2.3. 75 3.2.4. Trend Analysis of Profit after Taxation Table 3.2.4. 78 3.2.5.Trend Analysis of Total Shareholder's Fund Table 3.2.5. 80 3.2.6. Trend Analysis of Return on Shareholder's Fund Table 3.2.6. 83 Calculated results of Trend Equations and Square of Correlation Coefficient, Table 3.2( I ) 85 Year Wise Comparison, Table 3.2( II ) 85 Executive Summery GlaxoSmithKline is a world leading research based pharmaceutical Company, committed to improve the quality of human life by enabling people to do more, feel better and live longer. Pharmaceutical industry is one of the most complex and highly regulated industries in Bangladesh as elsewhere in the world. Although there is a price ceiling on the controlled priced products set by the government, still GlaxoSmithKline contributes around 100 crore Taka to the national exchequer and the amount is programming in an upward trend. The company has one of the most diversified marketing networks and efficient financing policies by which it ensures the availability of its products to the ultimate consumer and at the same time ensures good fund management. The Company always sets a selling target each year and tries to attain the goal. The Company also enjoys competitive advantage on its brand name. The Company has established 11 DMOs(District Marketing offices) in 11 districts, medicines are allocated to different demand oriented areas from these DMOs. The Company views Information System as a corporate resource and includes it as part of the strategic planning process. The maintenance of quality is a long-term fundamental aspect of the Company and they achieve it through their commitment to high international standards in every aspect of their business. GlaxoSmithKline is among the few companies in Bangladesh, which conducts their own research on millions of molecules to produce new medicines, for which they have some patent products. As far as the pharmaceutical industry is concerned, it is a highly competitive market and up to some extent, infact a great extent there is also the presence of a complex monopolistic market. Under these conditions the company has to set different sort of marketing and financing strategies.
Load more

Recommended publications
  • Glaxosmithkline Bangladesh Limited (GSK)
    GlaxoSmithKline Bangladesh Limited (GSK) Recruitment and Selection Process of GlaxoSmithKline Bangladesh Limited: An Evaluation nd Date of Submission: 2 September, 2014 ©Daffodil International University DAFFODIL INTERNATIONAL UNIVERSITY Internship Report On Recruitment and Selection Process of GlaxoSmithKline Bangladesh Limited: An Evaluation Submitted To Dr. Zakir Hossain Dean& Professor Faculty of Business & Economics Daffodil International University Submitted By Ishrat Jahan ID: 131-14-1019 Masters of Business Administration Daffodil International University Date of Submission: 2nd September, 2014 ©Daffodil International University Letter of Transmittal September 2, 2014 To Dr. Zakir Hossain Dean & Professor Faculty of Business and Economics Daffodil International University Dhaka-1205 Subject: Submission of internship report on recruitment and selection process: An evaluation of GlaxoSmithKline Bangladesh Limited Sir, I am highly satisfied to submit my report on recruitment and selection process: an evaluation of GSK. For preparing this report I tried my best to accumulate relevant and upgraded information from available sources. In preparing this report, I tried my level best to make it a complete one and sincerely look forward to any possible correction. I am very glad because you also given the opportunity to prepare this report .I hope that this report will meet the standards of your judgments. Your Sincerely ---------------- Ishrat Jahan ©Daffodil International University i Certificate of the Supervisor This is to certify that the internship report titled ―Recruitment and Selection Process of GlaxoSmithKline Bangladesh Limited: An Evaluation‖, has been prepared by Ms. Ishrat Jahan bearing ID: 131-14-1019 under my supervision, a practical study on GlaxoSmithKline Bangladesh Limited. I think on the basic of declaration Ms.
    [Show full text]
  • On Speed: the Many Lives of Amphetamine
    On Speed Nicolas Rasmussen On Speed The Many Lives of Amphetamine a New York University Press • New York and London NEW YORK UNIVERSITY PRESS New York and London www.nyupress.org © 2008 by New York University All rights reserved Library of Congress Cataloging-in-Publication Data Rasmussen, Nicolas, 1962– On speed : the many lives of amphetamine / Nicolas Rasmussen. p. ; cm. Includes bibliographical references and index. ISBN-13: 978-0-8147-7601-8 (cl : alk. paper) ISBN-10: 0-8147-7601-9 (cl : alk. paper) 1. Amphetamines—United States—History. 2. Amphetamine abuse— United States—History. I. Title. II. Title: Many lives of amphetamine. [DNLM: 1. Amphetamines—history—United States. 2. Amphetamine-Related Disorders—history—United States. 3. History, 20th Century—United States. 4. History, 21st Century—United States. QV 102 R225o 2007] RM666.A493R37 2007 362.29'90973—dc22 2007043261 New York University Press books are printed on acid-free paper, and their binding materials are chosen for strength and durability. Manufactured in the United States of America c10987654321 p10987654321 To my parents, Laura and Norman, for teaching me to ask questions Contents Acknowledgments ix Introduction 1 1 The New Sensation 6 2 Benzedrine: The Making of a Modern Medicine 25 3 Speed and Total War 53 4 Bootleggers, Beatniks, and Benzedrine Benders 87 5 A Bromide for the Atomic Age 113 6 Amphetamine and the Go-Go Years 149 7 Amphetamine’s Decline: From Mental Medicine to Social Disease 182 8 Fast Forward: Still on Speed, 1971 to Today 222 Conclusion: The Lessons of History 255 Notes 261 List of Archival Sources 347 Index 348 About the Author 352 Illustrations appear in two groups following pages 86 and 148.
    [Show full text]
  • GCE a Level 1083/01 BUSINESS STUDIES –
    GCE A level 1083/01 S15-1083-01 BUSINESS STUDIES – BS3 A.M. WEDNESDAY, 10 June 2015 2 hours 1083 010001 ADDITIONAL MATERIALS In addition to this examination paper, you will need: • a calculator; • a 12 page answer book. INSTRUCTIONS TO CANDIDATES Use black ink or black ball-point pen. Answer all the questions. Write your answers in the separate answer book provided. INFORMATION FOR CANDIDATES The number of marks is given in brackets at the end of each question. You are reminded that assessment will take into account the quality of written communication used in answers that involve extended writing in questions 4 and 5. You are reminded that questions 4 and 5 are synoptic and so will test understanding of the connections between different elements of the subject. © WJEC CBAC Ltd. AM*(S15-1083-01) 2 Study the information provided about GlaxoSmithKline plc and answer the questions that follow. BACKGROUND GlaxoSmithKline plc (GSK) is a science-led global healthcare company that researches and develops a broad range of innovative medicines and brands. It has three primary areas of business: pharmaceuticals, vaccines and consumer healthcare. Its consumer products include 5 Ribena, Macleans toothpaste, Panadol headache pills, Lucozade and Horlicks. The company can trace its history back to 1715 when Sylvanus Bevan established his pharmacy in Plough Court in London. In 1880, his descendants founded Burroughs Wellcome and Company which, eventually in 1995, merged with the Australian company Glaxo to form Glaxo Wellcome. The American branch of the business can trace its history back to 1830 when John K Smith 10 opened his first drugstore.
    [Show full text]
  • Gertrude B. Elion 1918 Cobb Street #2301 [email protected] New York, NY 10009 (555) 555-6789 Match Number 02211999
    Gertrude B. Elion 1918 Cobb Street #2301 [email protected] New York, NY 10009 (555) 555-6789 Match Number 02211999 EDUCATION Doctor of Pharmacy September 0000- June 0000 Brooklyn Polytechnic Institute New York, NY Bachelor of Science in Biology December 0000-March 0000 Hunter College New York, NY COMPLETED CLERKSHIP ROTATIONS Fairway Market: Kips Bay December 0000 Preceptor: Bertha Cohen, PharmD New York, NY Outpatient community pharmacy experience primarily serving a diverse adult population Provided counseling for patients receiving new medications and gave recommendations for over the counter products Recommended and administered vaccinations Communicated with pharmacies and clinics to receive verbal orders and prescription transfers New York City Pharmacy November 0000 Preceptor: George H. Hitchings, PharmD, James Buchanan, PharmD New York, NY Outpatient experience in both a retail pharmacy and a primary care clinic serving community members Provided counseling for patients receiving new medications and Suboxone Developed vaccine, anticoagulation, and weight management recommendations for patients seen at the travel clinic and at the health clinic Performed medication reconciliation and assisted pharmacists with refill authorizations at the primary care clinic Provided diabetes education and lifestyle counseling to those attending the Men’s Health Fair Wrote a literature evaluation on new medications for schizophrenia, bipolar disorder, and major depressive disorder Coler-Goldwater Specialty Hospital October 0000 Preceptor:
    [Show full text]
  • Glaxosmithkline ITA – Wikipedia
    GlaxoSmithKline - Wikipedia https://it.wikipedia.org/wiki/GlaxoSmithKline GlaxoSmithKline Da Wikipedia, l'enciclopedia libera. GlaxoSmithKline plc (Borsa di Londra: GSK (https://it.finance.yahoo.com/q?s=GSK.L), NYSE: GSK GlaxoSmithKline plc (https://www.nyse.com/quote/XNYS:GSK)) è una società britannica operante nel settore farmaceutico, biologico, e sanitario. GlaxoSmithKline è una società di ricerca con un vasto Stato Regno Unito portafoglio di prodotti farmaceutici che comprendono Forma Società per azioni antinfettivi del sistema nervoso centrale (SNC), societaria respiratorio, gastrointestinale/metabolico, oncologico e vaccini. Inoltre ha molti prodotti per l'igiene del Borse Borsa di Londra: GSK consumatore tra cui prodotti per l'igiene orale, bevande valori (https://it.finance.yahoo.com nutrizionali e medicinali da banco. È presente in 37 /q?s=GSK.L) nazioni ed in Italia possiede una sede a San Polo di NYSE: GSK Torrile, vicino a Parma. A Verona la Glaxo nasce il 30 (https://www.nyse.com marzo 1932 con il nome di Società anonima italiana /quote/XNYS:GSK) Nathan Bompiani, antesignana dell'odierna GlaxoSmithKline; dall'anno 2010 il centro ricerche di ISIN GB0009252882 Verona è condiviso con Aptuit[1]. L'Italia è stato il primo (http://www.isin.org/isin- insediamento estero dell'azienda che presto prenderà il preview nome Glaxo, dal greco "Galaktos", a simboleggiare uno /?isin=GB0009252882) dei suoi primi prodotti: il latte in polvere. Fondazione 2000 dalla fusione tra Glaxo Wellcome e SmithKline Beecham Indice Sede Londra principale
    [Show full text]
  • Marketing Plan & Promotional Activities of Prescribed Drug Makers
    Marketing plan & promotional activities of prescribed drug makers: A case study of CERVARIX (Vaccine of Cervical Cancer) of 1 GlaxoSmithKline Bangladesh Limited. Marketing plan & promotional activities of prescribed drug makers: A case study of CERVARIXTM (Vaccine of Cervical Cancer) of GlaxoSmithKline Bangladesh Limited. Prepared for Mr. Mahmudul Haq Assistant Professor, BRAC Business School BRAC University. Prepared by Md. Al Mamun ID: 10164010 (MBA) BRAC Business School Date of SUBMISSION: 23rd September, 2012 Marketing plan & promotional activities of prescribed drug makers: A case study of CERVARIX (Vaccine of Cervical Cancer) of 2 GlaxoSmithKline Bangladesh Limited. Preface To get the success of this report number of people has direct and indirect contribution. Some of the people gave the proper guideline and share their knowledge and few of them gave suggestion to carry out this report. I would like to say that the submission of the Internship report entitled “Marketing plan & promotional activities of prescribed drug makers: A case study of CERVARIX (Vaccine of Cervical Cancer) of GlaxoSmithKline Bangladesh Limited.” is a great achievement and delighting occasion for me. To this regard I would like to take the opportunity to express my gratitude to my faculty supervisor, Mr. Mahmudul Haq Assistant Professor, BRAC Business School BRAC University. His suggestions and comments to make the report a good one was really a great source of sprit for me. I would like thank my organization supervisor Shamim Rabbani, Commercial Director, GlaxoSmithKline Bangladesh Limited to share his valuable time and to guide me throughout the project. I sincerely believe that the road to improvement is never ending.
    [Show full text]
  • Tesis Martínez García Nadia.Pdf
    INSTITUTO POLITÉCNICO NACIONAL Escuela Superior de Comercio y Administración Unidad Santo Tomás Sección de Estudios de Posgrado e Investigación “Estrategias para disminuir la rotación de personal contratado a través de una empresa de tercerización de recursos humanos en el sector farmacéutico” Para obtener el grado de Maestría en Ciencias en Administración de Negocios PRESENTA: NADIA MARELI MARTÍNEZ GARCÍA DIRECTOR: DRA. SUSANA ASELA GARDUÑO ROMÁN México D.F. Marzo 2014 MAN I MAN INSTITUTO POLITÉCNICO NACIONAL SECRETARÍA DE INVESTIGACIÓN Y POSGRADO CARTA CESIÓN DE DERECHOS En la Ciudad de México D.F. el día 23 del mes de abril del año 2014, la que suscribe Nadia Mareli Martínez García alumna del Programa de Maestría en Ciencias en Administración de Negocios con número de registro A110654, adscrito a la Escuela Superior de Comercio y Administración Unidad Santo Tomás, manifiesta que es autora intelectual del presente trabajo de Tesis bajo la dirección de la Dra. Susana Asela Garduño Román y cede los derechos del trabajo intitulado “Estrategias para disminuir la rotación de personal contratado a través de una empresa de tercerización de recursos humanos en el sector farmacéutico”, al Instituto Politécnico Nacional para su difusión, con fines académicos y de investigación. Los usuarios de la información no deben reproducir el contenido textual, gráficas o datos del trabajo sin el permiso expreso del autor y/o director del trabajo. Este puede ser obtenido escribiendo a la siguiente dirección [email protected]. Si el permiso se otorga, el usuario deberá dar el agradecimiento correspondiente y citar la fuente del mismo. Nadia Mareli Martínez García Nombre y firma II MAN RESUMEN La rotación de personal impacta a las organizaciones, la economía y el mercado, por lo cual en esta tesis se aborda el tema enfocado al personal contratado vía una empresa de tercerización de recursos humanos para GlaxoSmithKline México.
    [Show full text]
  • Integracijski Procesi V Globalni Farmacevtski Panogi
    UNIVERZA V LJUBLJANI EKONOMSKA FAKULTETA MAGISTRSKO DELO INTEGRACIJSKI PROCESI V GLOBALNI FARMACEVTSKI PANOGI Ljubljana, julij 2013 GORAZD PUCELJ IZJAVA O AVTORSTVU Spodaj podpisani Gorazd Pucelj, študent Ekonomske fakultete Univerze v Ljubljani, izjavljam, da sem avtor magistrskega dela z naslovom Integracijski procesi v globalni farmacevtski panogi, pripravljenega v sodelovanju s svetovalcem prof. dr. Matejem Lahovnikom. Izrecno izjavljam, da v skladu z določili Zakona o avtorski in sorodnih pravicah (Ur. l. RS, št. 21/1995 s spremembami) dovolim objavo magistrskega dela na fakultetnih spletnih straneh. S svojim podpisom zagotavljam, da je predloženo besedilo rezultat izključno mojega lastnega raziskovalnega dela; je predloženo besedilo jezikovno korektno in tehnično pripravljeno v skladu z Navodili za izdelavo zaključnih nalog Ekonomske fakultete Univerze v Ljubljani, kar pomeni, da sem o poskrbel, da so dela in mnenja drugih avtorjev oziroma avtoric, ki jih uporabljam v magistrskem delu, citirana oziroma navedena v skladu z Navodili za izdelavo zaključnih nalog Ekonomske fakultete Univerze v Ljubljani, in o pridobil vsa dovoljenja za uporabo avtorskih del, ki so v celoti (v pisni ali grafični obliki) uporabljena v tekstu, in sem to v besedilu tudi jasno zapisal; se zavedam, da je plagiatorstvo – predstavljanje tujih del (v pisni ali grafični obliki) kot mojih lastnih – kaznivo po Kazenskem zakoniku (Ur. l. RS, št. 55/2008 s spremembami); se zavedam posledic, ki bi jih na osnovi predloženega magistrskega dela dokazano plagiatorstvo
    [Show full text]
  • 2003 Günlü¤Ü Kongre Gazetesi • 2004 • Say› : 3
    Erciyes t›p günleri başl›yor Öğretmenlerimiz bilime kol kanat olmaya devam Soru ve yan›tlarla Güneş yine Doğu’dan doğacak ediyor İnflamatuar Barsak Hastal›klar› Sayfa 3 Sayfa 7 Sayfa 8 UGH 2003 Günlü¤ü Kongre Gazetesi • 2004 • Say› : 3 Gençli¤i yetifltiriniz. Onlara ilim 21. Ulusal Gastroenteroloji Haftas›’n›n ve irfan›n müspet fikirlerini veriniz. Gelece¤in ayd›nl›¤›na onlarla kavuflacaks›n›z. çal›flmalar› bafllad›... K. Atatürk, 1927 21. Ulusal Gastroenteroloji Haftas› 31 Ağustos - 5 Eylül tarihleri aras›nda Antalya Mirage Park Resort Otel’de yap›lacakt›r. 21. UGH Kongre Başkan›: Doç. Dr. Burhan Şahin, Onursal Başkan: Prof. Dr. Özden Uzunalimoğlu Tek amac›m›z kongrenin bilimsel kalitesini ve klinikler aras› bilimsel rekabeti yükseltmek, bilgi paylafl›m›n› kolaylaflt›rmakt›r Değerli Ayr›ca, yine hemen her kongre- ce hem kongreye kat›lma olanağ› bu- de poster alanlar›nda yerlerini alan lamayanlar›n yararlanmas› ve hem Meslektaşlar›m; ama kat›l›mc›lar›n ilgisinden mah- de bilgilerin kal›c›l›ğ› sağlanm›ş ola- rum kalan poster sunumlar›na da bir cakt›r. 2004 y›l› içinde düzenlenecek ayr›cal›k verilmesi ve oluşturulacak Bunun yan›nda, 2 y›ld›r uygu- olan 21. Ulusal Gastroenteroloji bir seçici kurulca değerlendirilen lanmakta olan ve kongrenin eğitim- Haftas›, 31 Ağustos - 5 Eylül 2004 posterlerin, ‘posterlerden seçmeler’ sel yönüne katk›s›n›n önemli oldu- tarihlerinde "Antalya Mirage Park ad› alt›nda ayr› bir oturumda sunul- ğunu, ayr›ca bir renk de katt›ğ›n› dü- Resort Otel"de yap›lacakt›r. mas› kararlaşt›r›lm›şt›r.
    [Show full text]
  • Valuación Glaxosmithkline Plc
    UADE BUSINESS SCHOOL TRABAJO FINAL - VALUACIÓN GLAXOSMITHKLINE PLC PROMOCIÓN: 2017 COHORTE: Maestría en Dirección de Finanzas y Control (CFO) 56 DIRECTORA: Mg. Dominga del Rosario Amarfil MAESTRANDO: Lic. Gonzalo Martín D’Avola FECHA DE ENTREGA: 20 de diciembre de 2017 Trabajo Final – CFO 56 Maestrando: Gonzalo Martín D’Avola ABSTRACT The pharmaceutical industry has been undergoing a deep transformation since the end of 2013. Not only have there been several mergers and acquisitions, divestitures and downsize activities, (such as Bristol-Myers Squibb’s decision to cut down their diabetes franchise) but also there has been a strong investment in the Consumer Healthcare market as well as a strong focus on new treatment types. As many pharma companies foresee that the old business model of high margin products protected by patents is no longer sustainable with the growing pressure of generics and costs reduction from governments, they are nothing but forced to adopt new strategies that allow them be profitable and modern. In this context, GlaxoSmithKline Plc. (GSK) has been spotlighted in several situations since 2008, when Sir Andrew Witty became the CEO. On one hand, he led a big downsizing on 2009 that demanded a 3.6-billion-pound provision to manage all the changes in the organization, then the company lost two trials for bribery totaling a fine of 3.5 billion dollars and finally GSK got to an agreement with Novartis for a joint-venture creating a new legal entity for the Consumer business. In March 2016, Witty announced his retirement for March 2017, so the purpose of this valuation is to determine whether the market expectations for such a change are either positive or negative even though his replacement, Emma Walmsley, has been in the role for almost nine months.
    [Show full text]
  • Glaxosmithkline - Wikipedia
    GlaxoSmithKline - Wikipedia https://en.wikipedia.org/wiki/GlaxoSmithKline GlaxoSmithKline From Wikipedia, the free encyclopedia GlaxoSmithKline plc (GSK) is a British pharmaceutical company headquartered in Brentford, London. Established in 2000 by a merger of Glaxo Wellcome and GlaxoSmithKline SmithKline Beecham, GSK was the world's sixth largest pharmaceutical company as of 2015, after Pfizer, Novartis, Merck, Hoffmann-La Roche and Sanofi.[n 1][3] Emma Walmsley became CEO on 31 March 2017 and is the first female CEO of the company. The company has a primary listing on the London Stock Exchange and is a constituent of the FTSE 100 Index. As of August 2016 it had a market capitalisation of £81 billion (around $107 billion), the fourth largest on the London Stock Exchange.[4] It has a secondary listing on the New York Stock Exchange. GSK's drugs and vaccines earned £21.3 billion in 2013.[5] Its top-selling products that year were Advair, Avodart, Flovent, Augmentin, Lovaza and Lamictal. GSK's consumer products, which earned £5.2 billion in 2013, include Sensodyne and Aquafresh toothpaste, the malted-milk drink Horlicks, Abreva for cold sores, Breathe Right nasal strips, Nicoderm and Nicorette nicotine replacements, and Night Nurse, a cold remedy.[6] The company developed the first malaria vaccine, RTS,S, which it said in 2014 it would make available for five percent above cost.[7] Legacy products developed at GSK include several listed in the World Health Organization Model List of Essential Medicines, such as amoxicillin, mercaptopurine, pyrimethamine
    [Show full text]
  • Universidad Tecnológica Equinoccial Facultad De
    UNIVERSIDAD TECNOLÓGICA EQUINOCCIAL FACULTAD DE CIENCIAS SOCIALES Y COMUNICACIÓN LICENCIATURA EN RELACIONES PÚBLICAS Y COMUNICACIÓN ORGANIZACIONAL Trabajo de grado para la obtención del título de: Licenciada en Relaciones Públicas y Comunicación Organizacional ANÁLISIS DE LA IMPLEMENTACIÓN DE UN REGLAMENTO DE COMUNICACIÓN EN LA EFECTIVIDAD DE LA COMUNICACIÓN INTERNA EN GSK ECUADOR Autor: Karla Nataly Rojas Acaro Directora: María José Enríquez Quito - Ecuador Marzo - 2017 Agradecimiento Mi agradecimiento a Dios, a mis padres y hermanas por su apoyo incondicional, a Miguel por su soporte durante todo el desarrollo de este trabajo, a laboratorio GlaxoSmithKline Ecuador por permitirme realizar este análisis y en especial a mi directora María José Enríquez por impulsarme a concluir esta etapa educativa. iii Dedicatoria El presente trabajo está dedicado a mi hija Ana Paula, el motor que guía cada paso que doy, quiero ser un buen ejemplo en tu vida y demostrarte que todo esfuerzo tiene su recompensa y nunca es tarde para alcanzar tus objetivos. iv UNIVERSIDAD TECNOLÓGICA EQUINOCCIAL BIBLIOTECA UNIVERSITARIA FORMULARIO DE REGISTRO BIBLIOGRÁFICO PROYECTO DE TITULACIÓN DATOS DE CONTACTO CÉDULA DE IDENTIDAD: 1718002866 APELLIDO Y NOMBRES: Rojas Acaro Karla Nataly DIRECCIÓN: Calle N92B Pasaje OE3N Casa OE3-09 EMAIL: [email protected] TELÉFONO FIJO: 02 3431267 TELÉFONO MOVIL: 09 95624866 DATOS DE LA OBRA TITULO: Análisis de la implementación de un reglamento de comunicación en la efectividad de la comunicación interna en GSK Ecuador AUTOR
    [Show full text]